Tiemann Investment Advisors LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 2,859 shares of the healthcare conglomerate’s stock after selling 65 shares during the quarter. Tiemann Investment Advisors LLC’s holdings in UnitedHealth Group were worth $1,447,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in UNH. Howard Capital Management Group LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at $341,000. GSG Advisors LLC grew its position in UnitedHealth Group by 14.4% in the 3rd quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate’s stock worth $435,000 after purchasing an additional 94 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after buying an additional 180,479 shares during the last quarter. Rovin Capital UT ADV bought a new position in UnitedHealth Group in the 3rd quarter worth approximately $239,000. Finally, Atria Investments Inc increased its holdings in shares of UnitedHealth Group by 2.1% during the third quarter. Atria Investments Inc now owns 86,691 shares of the healthcare conglomerate’s stock valued at $50,686,000 after purchasing an additional 1,765 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on UNH shares. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $629.32.
UnitedHealth Group Trading Up 1.2 %
UnitedHealth Group stock opened at $493.35 on Monday. The business’s 50-day simple moving average is $513.78 and its 200-day simple moving average is $553.39. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market capitalization of $451.28 billion, a PE ratio of 31.83, a PEG ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the company posted $5.83 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.70%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.
Insider Activity
In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.33% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- How is Compound Interest Calculated?
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- How to Calculate Retirement Income: MarketBeat’s Calculator
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.